Literature DB >> 11085766

Whipple's disease.

R N Ratnaike1.   

Abstract

Whipple's disease is a systemic bacterial infection and the common though not invariable manifestations are diarrhoea, weight loss, abdominal pain, and arthralgia. Arthritis or arthralgia may be the only presenting symptom, predating other manifestations by years. Virtually all organs in the body may be affected, with protean clinical manifestations. Various immunological abnormalities, some of which may be epiphenomena, are described. The causative organism is Tropheryma whippelii. The disease is uncommon though lethal if not treated. Recent data suggest the disease occurs in an older age group than previously described. The characteristic histopathological features are found most often in the small intestine. These are variable villous atrophy and distension of the normal villous architecture by an infiltrate of foamy macrophages with a coarsely granular cytoplasm, which stain a brilliant magenta colour with PAS. These pathognomonic PAS positive macrophages may also be present in the peripheral and mesenteric lymph nodes and various other organs. The histological differential diagnoses include histoplasmosis and Mycobacterium avium-intercellulare complex. The clinical diagnosis of Whipple's disease may be elusive, especially if gastrointestinal symptoms are not present. A unique sign of CNS involvement, if present, is oculofacial-skeletal myorhythmia or oculomasticatory myorhythmia, both diagnostic of Whipple's disease. A small bowel biopsy is often diagnostic, though in about 30% of patients no abnormality is present. In patients with only CNS involvement, a stereotactic brain biopsy can be done under local anaesthetic. A recent important diagnostic test is polymerase chain reaction of the 16S ribosomal RNA of Tropheryma whippelii. Whipple's disease is potentially fatal but responds dramatically to antibiotic treatment. In this review the current recommended treatments are presented. The response to treatment should be monitored closely, as relapses are common. CNS involvement requires more vigorous treatment because there is a high rate of recurrence after apparently successful treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085766      PMCID: PMC1741844          DOI: 10.1136/pmj.76.902.760

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  79 in total

1.  Diagnosis and follow-up of Whipple's disease by amplification of the 16S rRNA gene of Tropheryma whippelii.

Authors:  B Pron; C Poyart; E Abachin; T Fest; C Belanger; C Bonnet; P Capelle; J F Bretagne; A Fabianek; L Girard; H Hagège; P Berche
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-01       Impact factor: 3.267

2.  Anonymous survey of blood donors by polymerase chain reaction for Tropheryma whippelii.

Authors:  S A Misbah; D Stirzaker; B Ozols; A Franks; N Mapstone
Journal:  QJM       Date:  1999-01

3.  Treatment of refractory Whipple disease with interferon-gamma.

Authors:  T Schneider; A Stallmach; A von Herbay; T Marth; W Strober; M Zeitz
Journal:  Ann Intern Med       Date:  1998-12-01       Impact factor: 25.391

4.  Whipple's disease.

Authors:  R C Pirola; M A Mishkel; G J Macdonald; A G Liddelow
Journal:  Med J Aust       Date:  1967-11-25       Impact factor: 7.738

5.  Whipple's disease with minimal intestinal involvement.

Authors:  S Moorthy; G Nolley; J A Hermos
Journal:  Gut       Date:  1977-02       Impact factor: 23.059

6.  Whipple's disease. An example of the value of the electron microscope in diagnosis, follow-up, and correlation of a pathologic process.

Authors:  W A Morningstar
Journal:  Hum Pathol       Date:  1975-07       Impact factor: 3.466

7.  Isolation and characterization of an aetiological agent in Whipple's disease.

Authors:  R L Clancy; W A Tomkins; T J Muckle; H Richardson; W E Rawls
Journal:  Br Med J       Date:  1975-09-06

8.  Homogeneity of 16S-23S ribosomal intergenic spacer regions of Tropheryma whippelii in Swiss patients with Whipple's disease.

Authors:  H P Hinrikson; F Dutly; M Altwegg
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

9.  Neurologic disease in patients with treated Whipple's disease.

Authors:  D L Knox; T M Bayless; F E Pittman
Journal:  Medicine (Baltimore)       Date:  1976-11       Impact factor: 1.889

10.  Vascular lesions of the gastrointestinal system in Whipple's disease.

Authors:  T N James; B H Bulkley; S P Kent
Journal:  Am J Med Sci       Date:  1984-10       Impact factor: 2.378

View more
  6 in total

1.  Whipple's disease of the appendix.

Authors:  H Hashim; S Ahmed; S Shami; I Saeed
Journal:  J R Soc Med       Date:  2001-12       Impact factor: 5.344

2.  From past sailors' eras to the present day: scurvy as a surprising manifestation of an uncommon gastrointestinal disease.

Authors:  Diogo Ferreira Branquinho; Miguel Pinto-Gouveia; Sofia Mendes; Carlos Sofia
Journal:  BMJ Case Rep       Date:  2015-09-16

3.  Evolutionary constraints on codon and amino acid usage in two strains of human pathogenic actinobacteria Tropheryma whipplei.

Authors:  Sabyasachi Das; Sandip Paul; Chitra Dutta
Journal:  J Mol Evol       Date:  2006-03-22       Impact factor: 2.395

4.  Current Insights in Whipple's Disease.

Authors:  Mark C. Flemmer; Ronald W. Flenner
Journal:  Curr Treat Options Gastroenterol       Date:  2003-02

5.  Whipple's disease scleral nodules: a novel presentation in 2 consecutive patients.

Authors:  Waleed K Alsarhani; Muhannad I Alkhalifah; Hind M Alkatan; Afaf L Alsolami; Azza M Y Maktabi; Adel H Alsuhaibani
Journal:  BMC Ophthalmol       Date:  2020-10-16       Impact factor: 2.209

6.  Delayed Diagnosis of Whipple's Disease Complicated by Jarisch-Herxheimer Reaction to Ceftriaxone Treatment: A Case Report and Literature Review.

Authors:  Marcus C C Clarke; Ric N Price
Journal:  Trop Med Infect Dis       Date:  2022-03-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.